Drug-induced endocrine blood pressure elevation

George R. Thompson, Katharina R. Beck, Alex Odermatt
2019-06-15

SCID:  54.1/zjy8j5xc
Patients with uncontrolled hypertension are at risk for cardiovascular complications. The majority of them suffers from unidentified forms of hypertension and a fraction has so-called secondary hypertension with an identifiable cause. The patient's medications, its use of certain herbal supplements and over-the-counter agents represent potential causal factors for secondary hypertension that are often overlooked. The current review focuses on drugs that are likely to elevate blood pressure by affecting the human endocrine system at the level of steroid synthesis or metabolism, mineralocorticoid receptor activity, or by affecting the catecholaminergic system. Drugs with known adverse effects but where benefits outweigh their risks, drug candidates and market withdrawals are reviewed. Finally, potential therapeutic strategies are discussed.
Publication Details
Publication Date
2019-06-15
Journal
Publisher
ISSN
Access Type
Author Information
Authors
George R. Thompson
Katharina R. Beck
Alex Odermatt
Explore More Research
Use the citation graph to discover related papers and expand your research horizons.
Click any node to explore
Download PDF
100%